Dr. Vladimir Grigoryants, MD, is a board-certified plastic surgeon specializing in cosmetic surgery of the body and face. His practice is located in the Verdugo Hills Hospital in Glendale. Dr. Vladimir Grigoryants provides his patients with effective and advanced plastic surgery techniques in the safest possible environment. He caters to patients from all over the United States as well as other countries.

Dr. Vladimir Grigoryants has been the recipient of innumerable awards for his landmark work in cosmetic surgery. Dr. Grigoryants was selected as a Los Angeles Top Doctor in the field of Plastic Surgery by Los Angeles Magazine in 2018 and by Pasadena Magazine in 2019.

By actual client testimonials, Dr. Vladimir Grigoryants has been described as a wonderful doctor and artist who restores confidence, and who is attuned to his patients’ needs, concerns and is diligent in their care. Dr. Vladimir Grigoryants is not a salesman, and you will not find any gimmicks or sales pitches in his office. During your initial consultation you will experience only the compassion of a doctor who wishes to help in any way he can.

He operates primarily in the Verdugo Hills Hospital in Glendale, California, but his hospital staff privileges extend to the Glendale Adventist Medical Center as well as surgery centers in Beverly Hills and Encino.

After graduating from Dartmouth Medical School with honors in Hanover, NH, Dr. Vladimir Grigoryants completed prerequisite training in General Surgery at the University of Michigan in Ann Arbor. He completed additional fellowship training in Surgical Critical Care at the University of Michigan. He then went on to accomplish comprehensive training in Plastic and Reconstructive Surgery at the University of Virginia in Charlottesville.

Dr. Vladimir Grigoryants is certified by the American Board of Plastic Surgery and the American Society of Plastic Surgeons.

Medical Licenses
California Medical License – active

Hospital Staff Privileges
Verdugo Hills Hospital,
Glendale, CA
Glendale Adventist Medical Center,
Glendale, CA
Surgery Centers Beverly Hills and Encino, CA

Certification
American Board of Plastic Surgery
American Society of Plastic Surgeons

Honors and Rewards

Dr. Grigoryants was selected as one of the top plastic surgeons by Consumer’s Research Council of America – Guide to America’s Top Surgeons 2014.

Dr. Vladimir Grigoryants was selected as one of the top plastic surgeons by Consumer’s Research Council of America – Guide to America’s Top Plastic Surgeons 2010.

Dr. Vladimir Grigoryants was selected as one of the top surgeons in 2009 by Consumer’s Research Council of America – Guide to America’s Top Surgeons 2009.

Dr. Vladimir Grigoryants is a recipient of the Patient’s Choice Award 2009.

Dr. Vladimir Grigoryants selected as one of Americas Top Plastic Surgeons 2010 by Consumer’s Research Council.

Dr. Vladimir Grigoryants was recognized as a Doctor of Excellence by The Leading Physician of The World publication 2011.

Raymond F. Morgan 6th Annual Research Award
for clinical research. Department of Plastic Surgery,
University of Virginia Health System.

Frederick A. Coller Surgical Society Jobst Award
for resident basic science research. Department of Surgery,
University of Michigan Hospitals.

Coller Research Fellowship Award,
Department of Surgery,
University of Michigan Hospitals.

Milton Bryants – Margaret Arnold Award,
for basic science research. Section of
Vascular Surgery, Department of Surgery, University Michigan Hospitals.

Arthur Native Surgical Scholar Award,
Dartmouth Medical School.

Mosenthal Surgical Society Award,
Dartmouth Medical School.

Frederic P. Lord Award in Anatomy, Dartmouth Medical School.

Letters of Distinction,
Departments of Physiology and Endocrinology,
Dartmouth Medical School.

Publications

Book Chapter

1. Vladimir Grigoryants, Narasinhma Dasika, Gilbert R. Upchurch. Aberrant Right
   Subclavian Artery. In: Upchurch GR and Henke PK, (eds.), Clinical Scenarios in Vascular Surgery.
   Philadelphia:Lippincott, Williams, Wilkins. 2004

Peer-reviewed Publications

1. Vladimir Grigoryants, Sarah Abdulazadeh, Xin Quan, Kant Y. Lin. An expanded predictive model to assess the risk of complications following breast reconstruction In preparation.
2. Vladimir Grigoryants, John A. Jane Jr., Kant Y. Lin,Salvage of a complicated meningomyelocele using Duragen and Alloderm. In print Pediatric Neurosurgery.
3. Vladimir Grigoryants, Kant Lin. Pediatric chondrodermatitis nodularis helicis: case report and review of the literature. In Print. Journal of Craniofacial Surgery.
4. Vladimir Grigoryants, Kevin K. Hannawa, Charles G. Pearce, Indranil Sinha, Gorav Ailawadi, Kristopher B. Deatrick, Derek T. Woodrum, Peter K. Henke, James C. Stanley, Matthew J. Eagleton, Gilbert R. Upchurch. Tamoxifen upregulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. .”Journal of Vascular Surgery. 2005;41:108-114.
5. Vladimir Grigoryants, Matthew J. Eagleton, Gilbert R.Upchurch. Bilateral external carotid artery aneurysms. Vascular. 2004;12:387-389.
6. Vladimir Grigoryants, Nicholas Watson, Gilbert Upchurch, James C. Stanley, Peter K. Henke. “Iliorenal bypass: indications and outcomes following 41 reconstructions Submitted to Annals of Vascular Surgery
7. Kevin K. Hannawa, BS; Jonathan L. Eliason, MD; Derek T. Woodrum, MD; Charles G. Pearce, BA; Karen J. Roelofs, DVM; Vladimir Grigoryants, MD; Matthew J. Eagleton, MD; Peter K. Henke, MD; Thomas W. Wakefield, MD; James C Stanley, MD; Gilbert R. Upchurch, Jr, MD. L-Selectin–Mediated Neutrophil Recruitment in Experimental Rodent Aneurysm Formation. Circulation. 2005;112:241-247.
8. Indranil Sinha, Jonathan L Eliason, Gorav Ailawadi, Kevin K Hannawa, Michael P Deogracias, Siddharth Bethi, John W Ford, Karen J Roelofs, Vladimir Grigoryants, Peter K Henke, James C Stanley, Gilbert R Upchurch. Early MT-1 MMP expression following following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery. 2004:136; 176-82.
9. Mathew Eagleton, Vladimir Grigoryants, DA Peterson, , David M. Williams, Peter K. Henke, Thomas W. Wakefield, James Stanley, Gilbert Upchurch. Endovascular treatment of abdominal aortic aneurysm is associated with a low incidence of deep venous thrombosis. J Vasc Surg. 2002 Nov;36 (5):912-6.
10. Gilbert R Upchurch, Jr., Peter K. Henke, Mathew J. Eagleton, Vladimir Grigoryants, Vita V. Sullivan, Thomas W. Wakefield, Lloyd A. Jacobs, Lazar J. Greenfield, James C. Stanley. Pediatric splanchnic arterial occlusive disease: Clinical relevance and operative treatment. J Vasc Surg 2002:35;860-867.
11. Alik Farber, Vladimir Grigoryants, Diane M. Pallack, Jack L. Cronenwett, Richard J. Powell. Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guerin: review of primary aortoduodenal fistula without abdominal aortic aneurysm J Vasc Surg. 2001;33:868-73.
12. Vladimir Grigoryants, Steven K. Sargent, Nicholas A. Shorter. Extralobar pulmonary sequestration receiving arterial supply from the innominate artery. Ped Rad. 2000;30:696-698.

Presentations

1. An expanded predictive model to assess the risk of complications following breast reconstruction. UVA Department of Plastic Surgery 50th Anniversary Meeting, Charlottesville, VA, June 23, 2006
2. An expanded predictive model to assess the risk of complications following breast reconstruction. Southeastern Society of Plastic and Reconstructive Surgeons Meeting, Sea Island, GA, June 5-7, 2006.
3. Tamoxifen upregulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. The 50th Frederick A. Coller Surgical Society Meeting, Nashville, TN, September 30- October, 1, 2004.
4. Differential regulation of the superoxide dismutase family in the rodent aneurysm model and rat aortic smooth muscle cells. The 2004 Association for Academic Surgery, Houston, TX, November 11-13, 2004.
5. Tamoxifen attenuates development of experimental abdominal aortic aneurysms by upregulating catalase. Society of Vascular Medicine and Biology. 15th Annual Scientific Sessions. Anaheim, CA, June 4-5, 2004.
6. Tamoxifen attenuates development of experimental abdominal aortic aneurysms. Moses Gunn Annual Surgical Research Meeting. Ann Arbor, MI, April 30, 2004
7. Iliorenal bypass: An effective alternative to aortorenal reconstruction in select patients with renovascular occlusive disease, Midwestern Vascular Surgical 26th Annual Meeting. Madison, WI, September 12-14, 2002.
8. Iliorenal bypass: An effective alternative to aortorenal reconstruction in select patients with renovascular occlusive disease, Frederick A. Coller Surgical Society 48th Clinical Meeting Sea Island, GA, October 17-20, 2002.